CClinicalTrials.gg
CompletedNCT00889785Updated Dec 18, 2013

Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT)

An interventional study of Comprehensive intervention (disease management program) and Usual Care in Adolescents With Type 2 Diabetes, sponsored by Vanderbilt University. Completed at 1 site in United States. Open to participants aged 12 Years to 19 Years. Per ClinicalTrials.gov, last updated 2013-12-18.

Sponsored by Vanderbilt University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
12 Years to 19 Years
Sex
All
01

Study summary

The proposed research will test a new comprehensive disease management intervention with adolescents who have type 2 diabetes using a randomized controlled trial (RCT). Adolescents subjects with a history of Type 2 Diabetes and a parent caregiver will be consented, enrolled, and randomly assigned to either an 6-month intervention (N=44) or a "usual care" comparison (N=44). Recruitment will take place within the Vanderbilt Eskind Pediatric Diabetes Clinic. The intervention will include participation in a comprehensive disease management program that includes: (1) application of treatment algorithms, (2) phone assessment from a diabetes nurse practitioner and dietician to assess barriers and promote problem solving, treatment adherence and management, and (3) a behavioral Internet-administered self-management problem solving component. Outcomes include self-reported self-management behaviors (exercise, diet, medication adherence, etc.), blood pressure, weight/BMI, and glycated hemoglobin (A1C).

02

Conditions studied

  • Adolescents With Type 2 Diabetes

Keywords

  • Adolescents
  • Type 2 Diabetes
  • Behavioral Research
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 43 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Vanderbilt University is the lead sponsor of 508 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Patients with a diagnosis of T2DM will be included if they are:

  1. Age 12-19 years
  2. A clinical diagnosis of T2DM (according to the patient and their health provider in the clinic)
  3. Actively receive diabetes care in the Eskind Diabetes Clinic
  4. Willingness of patient and a caregiver to access the Internet to complete problem solving activities
  5. Adolescent address is the same as their primary caregiver participating in the study

Exclusion criteria

Exclusion Criteria:

Patients will be excluded if they meet any of the following:

  1. Identify an outside practitioner as the main provider of their diabetes care
  2. Have a significant psychiatric illness such as severe depression or active psychosis that would impact on the ability to participate in the study
  3. Life expectancy of \<6 months
  4. Unable to access the Internet from any convenient location
  5. Blind or deaf

Parent Inclusion criteria:

  1. Parents must be a primary caregiver of an adolescent with a diagnosis of T2DM between the ages 12-19 seen at the Eskind Clinic
  2. Willingness of patient and a caregiver to access the Internet to complete problem solving activities.

Parent Exclusion criteria:

Patients will be excluded if they meet any of the following:

  1. Identify an outside practitioner as the main provider of their child's diabetes care
  2. Self report of significant psychiatric illness such as severe depression or active psychosis that would impact on the ability to participate in the study
  3. life expectancy of \<6 months
  4. unable to access the Internet from any convenient location
  5. blind or deaf.

Joint Inclusion criteria:

Both the primary caregiver (parent) and adolescent must agree to participate in the research.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
43 participants (actual)

Study arms

  • Active comparator
    1 (Usual Care)

    Patients will continue to review usual care in the diabetes clinic. Patients will receive monthly phone calls as an active control condition.

    Behavioral: Usual Care

  • Experimental
    Intervention

    The intervention will include participation in a comprehensive disease management program that includes: (1) application of treatment algorithms, (2) phone assessment from a diabetes nurse practitioner and dietician to assess barriers and promote problem solving, treatment adherence and management, and (3) a behavioral Internet-administered self-management problem solving component.

    Behavioral: Comprehensive intervention (disease management program)

Interventions

  • BehavioralComprehensive intervention (disease management program)

    The intervention will include participation in a comprehensive disease management program that includes: (1) application of treatment algorithms, (2) phone assessment from a diabetes nurse practitioner and dietician to assess barriers and promote problem solving, treatment adherence and management, and (3) a behavioral Internet-administered self-management problem solving component.

  • BehavioralUsual Care

    Will receive usual care and monthly phone calls as an active control.

06

What researchers measure

Primary outcomes

  1. A1C

    Time frame: 0,3,6 months

  2. Lipids

    Time frame: 0,3,6 months

Secondary outcomes

  1. blood pressure

    Time frame: 0,3,6 months

  2. self-care behaviors

    Time frame: 0,3,6 months

07

Study locations

1 site
  • Vanderbilt Univ Medical Center
    Nashville, Tennessee 37232, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00889785
Lead sponsor
Vanderbilt University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Russell Rothman (Associate Professor, Vanderbilt University) — Principal investigator
First posted
Apr 29, 2009
Start date
Jun 2009
Primary completion
Aug 2011
Completion
Aug 2011
Last update
Dec 18, 2013

Study contacts

Russell L Rothman, MD MPP
principal investigator · Vanderbilt University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion